No changes were observed compared to the 18FDG PET/CT 2 months earlier: in size, the lesions were unchanged; however, the SUVmax was lower in all lesions on the 68Ga-PSMA PET/CT relative to the 18FDG PET/CT; in the thyroid lesion and the parasternal lymph node metastasis, there was only slight tracer uptake. Here, FOLH1 is linked to metastatic malignant neoplasm in the lymph nodes.